Publication | Open Access

Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers

UrologyGenitourinary CancerMedicinePhase Ii StudyCancer TreatmentOncologyRadiation OncologyMolecular ResponseClinical ActivityMolecular Oncology